Poietis Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 35
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $6.23M
Latest Deal Amount
  • Investors
  • 2

Poietis General Information


Developer of a 4D Bioimprinting technology intended to help the cosmetic and pharmaceutical industries. The company's platform develops and produces human, customized tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine, enabling tissue engineers and researchers to get greater freedom in the choice of biomaterials and hydrogels and greater versatility in their research and development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Bioparc Bordeaux Métropole, Bâtiment C - 1st floor
  • 27 allée Charles Darwin
  • 33600 Pessac
  • France
+33 05 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Poietis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 27-Mar-2018 $6.23M 00.000 000.00 Completed Generating Revenue
3. Equity Crowdfunding 15-Jan-2016 00.000 00000 00.000 Completed Generating Revenue
2. Angel (individual) 15-Oct-2014 $178K $178K 00.000 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2014 Completed Generating Revenue
To view Poietis’s complete valuation and funding history, request access »

Poietis Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 840 $1.232613 $205.85 $205.85 1x $205.85 3.36%
To view Poietis’s complete cap table history, request access »

Poietis Executive Team (4)

Name Title Board Seat Contact Info
Fabien Guillemot Ph.D Co-Founder, Chief Scientific Officer & Chief Executive Officer
Bertrand Viellerobe Chief Technology Officer
Bruno Brisson Founder, General Manager & Chief Business Officer
Delphine Fayol Ph.D Chief Products Officer
To view Poietis’s complete executive team members history, request access »

Poietis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Poietis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AQUITI Gestion Venture Capital Minority 000 0000 000000 0
Incubateur Régional d'Aquitaine Accelerator/Incubator 000 0000 000000 0
To view Poietis’s complete investors history, request access »